Center of Clinical Neuroscience

Long-term efficacy and safety of alemtuzumab in participants with highly active MS: TOPAZ clinical trial and interim analysis of TREAT-MS real-world study

Link

https://doi.org/10.1177/17562864241306575

Tags

Multiple SkleroseMS Behandlung

Jahr

2025

Autoren

Ziemssen T, Bass AD, Van Wijmeersch B, Eichau S, Richter S, Hoffmann F, Armstrong NM, Chirieac M, Cunha-Santos J, Singer BA.

Verlag

Ther Adv Neurol Disord. 2025 Feb 10;18:17562864241306575.

Zum Eintrag

Long-Term Treatment With Ocrelizumab in Patients With Early-Stage Relapsing MS

Link

https://doi.org/10.1212/WNL.0000000000210142

Tags

Multiple SkleroseMS Behandlung

Jahr

2025

Autoren

Cerqueira JJ, Berthele A, Cree BAC, Filippi M, Pardo G, Pearson OR, Traboulsee A, Ziemssen T, Vollmer T, Bernasconi C, Mandel CR, Kulyk I, Chognot C, Raposo C, Schneble HM, Thanei GA, Incera E, Havrdová EK.

Verlag

Neurology. 2025 Feb 25;104(4):e210142.

Zum Eintrag

A plain language summary of a study exploring the experiences of people with relapsing–remitting multiple sclerosis: what symptoms and impacts of the disease matter most and how can they be evaluated better?

Link

https://doi.org/10.1080/17582024.2024.2441068

Tags

Multiple SkleroseMS Behandlung

Jahr

2025

Autoren

Barrett Amy, Olayinka-Amao O, Ziemssen T, Bharadia T, Henke C, Kamudoni P.

Verlag

Neurodegenerative Disease Management, January, 1–8.

Zum Eintrag

Best supportive care for patients with primary progressive multiple sclerosis (PPMS) in Germany prior to ocrelizumab treatment: Final results from the RETRO PPMS study

Link

https://doi.org/10.1177/11795735241296001

Tags

Multiple SkleroseMS Behandlung

Jahr

2024

Autoren

Schreiber H, Penner I-K, Maier T, Hieke-Schulz S, Leemhuis J, Ziemssen T.

Verlag

Journal of Central Nervous System Disease. 2024;16.

Zum Eintrag

Eculizumab Use in Neuromyelitis Optica Spectrum Disorders

Link

https://doi.org/10.1212/wnl.0000000000209888

Tags

MS BehandlungAndere

Jahr

2024

Autoren

Ringelstein M, Asseyer S, Lindenblatt G, Fischer K, Pul R, Skuljec J, Revie L, Giglhuber K, Häußler V, Karenfort M, Hellwig K, Paul F, Bellmann-Strobl J, Otto C, Ruprecht K, Ziemssen T, Emmer A, Rothhammer V, Nickel FT, Angstwurm K, Linker R, Laurent SA, Warnke C, Jarius S, Korporal-Kuhnke M, Wildemann B, Wolff S, Seipelt M, Yalachkov Y, Retzlaff N, Zettl UK, Rommer PS, Kowarik MC, Wickel J, Geis C, Hümmert MW, Trebst C, Senel M, Gold R, Klotz L, Kleinschnitz C, Meuth SG, Aktas O, Berthele A, Ayzenberg I; German Neuromyelitis Optica Study Group (NEMOS).

Verlag

Neurology. 2024 Nov 12;103(9):e209888.

Zum Eintrag